Evidence map›Paper›PMID 25916733›Full record

SynthesisEpidemiology and infection2015

Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.

L Telisinghe, T D Waite, M Gobin, O Ronveaux, K Fernandez, J M Stuart, R J P M Scholten

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Epidemiology and infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

L TelisingheField Epidemiology Services,Public Health England,Bristol,UK.
T D WaiteField Epidemiology Services,Public Health England,Bristol,UK.
M GobinField Epidemiology Services,Public Health England,Bristol,UK.
O RonveauxWorld Health Organization,Geneva,Switzerland.
K FernandezWorld Health Organization,Geneva,Switzerland.
J M StuartUniversity of Bristol,Bristol,UK.
R J P M ScholtenDutch Cochrane Centre/Julius Center for Health Sciences and Primary Care,University Medical Center Utrecht,Utrecht,The Netherlands.
Public Health England · GBWorld Health Organization · CHLondon School of Hygiene & Tropical Medicine · GBUniversity Medical Center Utrecht · NLUniversity of Bristol · GB

Funding

World Health Organization 001
6 · The paper itself

Abstract

Household contacts of an index case of invasive meningococcal disease (IMD) are at increased risk of acquiring disease. In revising WHO guidance on IMD in sub-Saharan Africa, a systematic review was undertaken to assess the effect of chemoprophylaxis and of vaccination in preventing subsequent cases of IMD in household contacts following an index case. A literature search for systematic reviews identified a single suitable review on chemoprophylaxis in 2004 (three studies meta-analysed). A search for primary research papers published since 2004 on chemoprophylaxis and without a date limit on vaccination was therefore undertaken. There were 2381 studies identified of which two additional studies met the inclusion criteria. The summary risk ratio for chemoprophylaxis vs. no chemoprophylaxis (four studies) in the 30-day period after a case was 0·16 [95% confidence interval (CI) 0·04-0·64, P = 0·008]; the number needed to treat to prevent one subsequent case was 200 (95% CI 111-1000). A single quasi-randomized trial assessed the role of vaccination. The risk ratio for vaccination vs. no vaccination at 30 days was 0·11 (95% CI 0·01-2·07, P = 0·14). The results support the use of chemoprophylaxis to prevent subsequent cases of IMD in household contacts of a case. Conclusions about the use of vaccination could not be drawn.

Indexed as

Family CharacteristicsAnti-Bacterial AgentsChemopreventionHumansMeningitis, MeningococcalMeningococcal InfectionsMeningococcal VaccinesOdds RatioTreatment OutcomeAnti-Bacterial AgentsMeningococcal VaccinesInfectious disease controlmeningococcal diseasemeningococcus (N. meningitis)Neisseria meningitidesprevention

Identifiers

PMID25916733
PMCPMC9150978
OpenAlexW2167651930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.